|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 801 to 900 out of 903 for Cdk4

0.077s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Saab R
Year: 2009
Journal: Cancer Res
Title: p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
Volume: 69
Issue: 2
Pages: 440-8
Publication
First Author: Muraoka RS
Year: 2001
Journal: J Cell Biol
Title: Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function.
Volume: 153
Issue: 5
Pages: 917-32
Publication
First Author: Bailly-Maitre B
Year: 2007
Journal: Cancer Res
Title: Mice lacking bi-1 gene show accelerated liver regeneration.
Volume: 67
Issue: 4
Pages: 1442-50
Publication  
First Author: Li F
Year: 2017
Journal: Eur J Pharmacol
Title: Activation of PPARĪ³ inhibits HDAC1-mediated pulmonary arterial smooth muscle cell proliferation and its potential mechanisms.
Volume: 814
Pages: 324-334
Publication
First Author: Ueberham U
Year: 2014
Journal: Neuropathol Appl Neurobiol
Title: Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease.
Volume: 40
Issue: 7
Pages: 815-32
Publication
First Author: Zhuang SM
Year: 2000
Journal: Cancer Lett
Title: Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas.
Volume: 152
Issue: 2
Pages: 129-34
Publication
First Author: Bagui TK
Year: 2000
Journal: Mol Cell Biol
Title: Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
Volume: 20
Issue: 23
Pages: 8748-57
Publication
First Author: Linardopoulos S
Year: 1995
Journal: Cancer Res
Title: Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
Volume: 55
Issue: 22
Pages: 5168-72
Publication
First Author: Okuda T
Year: 1995
Journal: Genomics
Title: Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
Volume: 29
Issue: 3
Pages: 623-30
Publication
First Author: Ewen ME
Year: 1996
Journal: Biochim Biophys Acta
Title: p53 and translational control.
Volume: 1242
Issue: 3
Pages: 181-4
Publication
First Author: Palmero I
Year: 1997
Journal: Oncogene
Title: Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status.
Volume: 15
Issue: 5
Pages: 495-503
Publication
First Author: Sinha R
Year: 1997
Journal: Carcinogenesis
Title: Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells.
Volume: 18
Issue: 8
Pages: 1541-7
Publication
First Author: Goisset C
Year: 1998
Journal: Mech Dev
Title: Identification and developmental expression of cyclin-dependent kinase 4 gene in Xenopus laevis.
Volume: 70
Issue: 1-2
Pages: 197-200
Publication
First Author: CoppƩe F
Year: 1998
Journal: Oncogene
Title: Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Volume: 17
Issue: 5
Pages: 631-41
Publication
First Author: Wang QS
Year: 1998
Journal: Carcinogenesis
Title: Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.
Volume: 19
Issue: 11
Pages: 2001-6
Publication
First Author: PĆ©rez de Castro IP
Year: 1999
Journal: Carcinogenesis
Title: Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
Volume: 20
Issue: 9
Pages: 1675-82
Publication
First Author: Pirkmaier A
Year: 2003
Journal: Oncogene
Title: Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Volume: 22
Issue: 28
Pages: 4425-33
Publication  
First Author: Malumbres M
Year: 2003
Journal: Adv Exp Med Biol
Title: Driving the cell cycle to cancer.
Volume: 532
Pages: 1-11
Publication
First Author: Yamamoto M
Year: 2006
Journal: Mol Carcinog
Title: Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis.
Volume: 45
Issue: 12
Pages: 901-13
Publication
First Author: Carbone CJ
Year: 2007
Journal: Cancer Res
Title: p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
Volume: 67
Issue: 9
Pages: 4130-7
Publication
First Author: Theodoraki MA
Year: 2007
Journal: Exp Cell Res
Title: Akt shows variable sensitivity to an Hsp90 inhibitor depending on cell context.
Volume: 313
Issue: 18
Pages: 3851-8
Publication
First Author: Hu G
Year: 2001
Journal: Development
Title: Msx homeobox genes inhibit differentiation through upregulation of cyclin D1.
Volume: 128
Issue: 12
Pages: 2373-84
Publication
First Author: Liao HS
Year: 2001
Journal: Circ Res
Title: Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes.
Volume: 88
Issue: 4
Pages: 443-50
Publication
First Author: Gonzalez YR
Year: 2008
Journal: J Neurosci
Title: CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage.
Volume: 28
Issue: 21
Pages: 5559-69
Publication
First Author: Salisbury E
Year: 2008
Journal: Exp Cell Res
Title: Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1.
Volume: 314
Issue: 11-12
Pages: 2266-78
Publication
First Author: Macias E
Year: 2008
Journal: Am J Pathol
Title: CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development.
Volume: 173
Issue: 2
Pages: 526-35
Publication
First Author: Renner O
Year: 2008
Journal: Cancer Res
Title: Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
Volume: 68
Issue: 23
Pages: 9643-53
Publication
First Author: Kaproth-Joslin KA
Year: 2008
Journal: Biochem J
Title: Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
Volume: 415
Issue: 3
Pages: 439-48
Publication
First Author: Joshi I
Year: 2009
Journal: Blood
Title: Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Volume: 113
Issue: 8
Pages: 1689-98
Publication
First Author: Blancquaert S
Year: 2010
Journal: Mol Endocrinol
Title: cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.
Volume: 24
Issue: 7
Pages: 1453-68
Publication
First Author: Badhai J
Year: 2009
Journal: Biochim Biophys Acta
Title: Ribosomal protein S19 and S24 insufficiency cause distinct cell cycle defects in Diamond-Blackfan anemia.
Volume: 1792
Issue: 10
Pages: 1036-42
Publication
First Author: Wang X
Year: 2011
Journal: Am J Pathol
Title: Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.
Volume: 178
Issue: 1
Pages: 345-54
Publication
First Author: Ueberham U
Year: 2012
Journal: Neurobiol Aging
Title: Transcriptional control of cell cycle-dependent kinase 4 by Smad proteins--implications for Alzheimer's disease.
Volume: 33
Issue: 12
Pages: 2827-40
Publication
First Author: Panda DK
Year: 2012
Journal: Am J Physiol Endocrinol Metab
Title: Defective postnatal endochondral bone development by chondrocyte-specific targeted expression of parathyroid hormone type 2 receptor.
Volume: 303
Issue: 12
Pages: E1489-501
Publication
First Author: Khanjyan MV
Year: 2013
Journal: Hum Mol Genet
Title: A high-content, high-throughput siRNA screen identifies cyclin D2 as a potent regulator of muscle progenitor cell fusion and a target to enhance muscle regeneration.
Volume: 22
Issue: 16
Pages: 3283-95
Publication
First Author: Chang KH
Year: 2012
Journal: J Cell Sci
Title: Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
Volume: 125
Issue: Pt 21
Pages: 5124-37
Publication
First Author: DiRocco DP
Year: 2014
Journal: Am J Physiol Renal Physiol
Title: CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury.
Volume: 306
Issue: 4
Pages: F379-88
Publication
First Author: Kangwan N
Year: 2016
Journal: Int J Cancer
Title: Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
Volume: 138
Issue: 6
Pages: 1482-93
Publication
First Author: Li W
Year: 2015
Journal: PLoS One
Title: Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation.
Volume: 10
Issue: 5
Pages: e0126459
Publication
First Author: Ito H
Year: 2016
Journal: Biochim Biophys Acta
Title: Schizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of cyclin D1.
Volume: 1862
Issue: 8
Pages: 1383-91
Publication
First Author: Zhang J
Year: 2018
Journal: Nature
Title: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Volume: 553
Issue: 7686
Pages: 91-95
Publication
First Author: Yuan J
Year: 2015
Journal: Oncotarget
Title: Accelerated hepatocellular carcinoma development in CUL4B transgenic mice.
Volume: 6
Issue: 17
Pages: 15209-21
Publication
First Author: Luo C
Year: 2020
Journal: Cancer Res
Title: Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency.
Volume: 80
Issue: 16
Pages: 3215-3221
Publication  
First Author: Guo L
Year: 2020
Journal: Arch Biochem Biophys
Title: S-petasin induces apoptosis and inhibits cell migration through activation of p53 pathway signaling in melanoma B16F10Ā cells and A375Ā cells.
Volume: 692
Pages: 108519
Publication
First Author: Suzuki R
Year: 2015
Journal: J Crohns Colitis
Title: Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
Volume: 9
Issue: 7
Pages: 565-74
Publication
First Author: Matsushime H
Year: 1991
Journal: Cell
Title: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.
Volume: 65
Issue: 4
Pages: 701-13
Publication  
First Author: Hall M
Year: 1996
Journal: Adv Cancer Res
Title: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
Volume: 68
Pages: 67-108
Publication
First Author: Xiong Y
Year: 1991
Journal: Cell
Title: Human D-type cyclin.
Volume: 65
Issue: 4
Pages: 691-9
Publication  
First Author: Kato J
Year: 1999
Journal: Front Biosci
Title: Induction of S phase by G1 regulatory factors.
Volume: 4
Pages: D787-92
Publication
First Author: Resnitzky D
Year: 1995
Journal: Mol Cell Biol
Title: Different roles for cyclins D1 and E in regulation of the G1-to-S transition.
Volume: 15
Issue: 7
Pages: 3463-9
Protein Domain
Type: Family
Description: Cyclins are eukaryotic proteins that play an active role in controlling nuclear cell division cycles [], and regulate cyclin dependent kinases (CDKs). Cyclins, together with the p34 (cdc2) or cdk2 kinases, form the Maturation Promoting Factor (MPF). There are two main groups of cyclins, G1/S cyclins, which are essential for the control of the cell cycle at the G1/S (start) transition, and G2/M cyclins, which are essential for the control of the cell cycle at the G2/M (mitosis) transition. G2/M cyclins accumulate steadily during G2 and are abruptly destroyed as cells exit from mitosis (at the end of the M-phase). In most species, there are multiple forms of G1 and G2 cyclins. For example, in vertebrates, there are two G2 cyclins, A and B, and at least three G1 cyclins, C, D, and E.Cyclin homologues have been found in various viruses, including Saimiriine herpesvirus 2 (Herpesvirus saimiri) and Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus). These viral homologues differ from their cellular counterparts in that the viral proteins have gained new functions and eliminated others to harness the cell and benefit the virus [].Among G1 regulators, D-type cyclins serve as targets of growth factors to integrate extracellular signals into the core cell cycle regulators. D-type cyclins were identified in three independent approaches; (I) a target gene of chromosomal translocations in a variety of cancers [], (II) a mammalian cyclin gene that can complement yeast G1 cyclin deficiency [], and (III) a delayed early growth factor inducible gene []. D-type cyclins are composed of three different but closely related subfamilies (D1, D2, and D3), all differentially expressed in a wide variety of organs and in a tissue-specific manner. Expression of D-type cyclins is induced in response to a variety of mitogenic signals and they function as a regulatory subunit of cyclin-dependent kinases (Cdk).D-type cyclins can interact with 4 different Cdks (Cdk2, 4, 5, and 6), among which Cdk4 and Cdk6 are apparently the major functional catalytic partners in proliferating cells. When cells are exposed to growth factor stimulation, the expression of cyclin D is maintained regardless of the point in the cell cycle. However, accumulation of active cyclin D/Cdk4 (or Cdk6) complex is rate-limiting and is required for cells to progress through G1 and to commit to entering S phase. The over expression of D-type cyclins shortens the length of G1 without affecting remainder of the cell cycle. This event is clearly different from phenotype of the cells over expressing another G1 cyclin, cyclin E, in which G1 is shortened but elongation of the S phase compensates this shortening and as a result, doubling time of the cell remains unchanged. Thus, the cyclin D/Cdk4 complex largely exerts effects on commitment of cells for the S phase entry during the G1 phase, while functions of cyclin E/Cdk2 kinase are more directly involved in the initiation of chromosomal DNA synthesis [, ].This entry is comprised of D-type cyclins that are evolutionarily conserved across a variety of species.
Publication
First Author: Matsuoka M
Year: 1994
Journal: Mol Cell Biol
Title: Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
Volume: 14
Issue: 11
Pages: 7265-75
Publication
First Author: Karst AM
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
Volume: 108
Issue: 18
Pages: 7547-52
Publication
First Author: Walter DM
Year: 2019
Journal: Nature
Title: RB constrains lineage fidelity and multiple stages of tumour progression and metastasis.
Volume: 569
Issue: 7756
Pages: 423-427
Publication
First Author: Zhao X
Year: 2019
Journal: Am J Physiol Endocrinol Metab
Title: Involvement of the STAT5-cyclin D/CDK4-pRb pathway in Ī²-cell proliferation stimulated by prolactin during pregnancy.
Volume: 316
Issue: 1
Pages: E135-E144
Publication  
First Author: Novais EJ
Year: 2019
Journal: Matrix Biol
Title: p16Ink4a deletion in cells of the intervertebral disc affects their matrix homeostasis and senescence associated secretory phenotype without altering onset of senescence.
Volume: 82
Pages: 54-70
Publication
First Author: Malstrom S
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus.
Volume: 98
Issue: 26
Pages: 14967-72
Publication
First Author: Tateishi Y
Year: 2012
Journal: Biochem Biophys Res Commun
Title: Development of mice without Cip/Kip CDK inhibitors.
Volume: 427
Issue: 2
Pages: 285-92
Publication
First Author: Franklin DS
Year: 2000
Journal: Mol Cell Biol
Title: Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity.
Volume: 20
Issue: 16
Pages: 6147-58
Publication
First Author: Sabourin CL
Year: 1998
Journal: Exp Lung Res
Title: Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors.
Volume: 24
Issue: 4
Pages: 499-521
Publication
First Author: Zhang T
Year: 1997
Journal: Cancer Res
Title: Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Volume: 57
Issue: 9
Pages: 1638-43
Publication
First Author: Nguyen MD
Year: 2003
Journal: J Neurosci
Title: Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.
Volume: 23
Issue: 6
Pages: 2131-40
Publication
First Author: Guo S
Year: 2019
Journal: FASEB J
Title: 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice.
Volume: 33
Issue: 9
Pages: 10207-10217
Publication
First Author: Halaban R
Year: 1999
Journal: Cancer Metastasis Rev
Title: Melanoma cell autonomous growth: the Rb/E2F pathway.
Volume: 18
Issue: 3
Pages: 333-43
Publication
First Author: Agrawal D
Year: 1996
Journal: Mol Cell Biol
Title: Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells.
Volume: 16
Issue: 8
Pages: 4327-36
Publication
First Author: Said TK
Year: 1996
Journal: Cell Prolif
Title: Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
Volume: 29
Issue: 11
Pages: 623-39
Publication
First Author: Sherburn TE
Year: 1998
Journal: DNA Cell Biol
Title: Cloning and characterization of the CDKN2A and p19ARF genes from Monodelphis domestica.
Volume: 17
Issue: 11
Pages: 975-81
Publication
First Author: Balasubramanian S
Year: 1999
Journal: Oncogene
Title: Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse.
Volume: 18
Issue: 6
Pages: 1297-302
Publication
First Author: Kang Y
Year: 2002
Journal: Carcinogenesis
Title: Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.
Volume: 23
Issue: 7
Pages: 1217-27
Publication
First Author: Vax VV
Year: 2003
Journal: J Endocrinol
Title: Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
Volume: 178
Issue: 2
Pages: 301-10
Publication
First Author: Hino S
Year: 2004
Journal: Diabetologia
Title: In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.
Volume: 47
Issue: 10
Pages: 1819-30
Publication
First Author: Hacker E
Year: 2008
Journal: Int J Cancer
Title: Reduced expression of IL-18 is a marker of ultraviolet radiation-induced melanomas.
Volume: 123
Issue: 1
Pages: 227-31
Publication
First Author: Li B
Year: 2010
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Pancreatic acinar-specific overexpression of Reg2 gene offered no protection against either experimental diabetes or pancreatitis in mice.
Volume: 299
Issue: 2
Pages: G413-21
Publication
First Author: Vaid M
Year: 2010
Journal: Carcinogenesis
Title: Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
Volume: 31
Issue: 11
Pages: 2004-11
Publication
First Author: Mukhopadhyay P
Year: 2016
Journal: Oncogene
Title: Murine melanomas accelerated by a single UVR exposure carry photoproduct footprints but lack UV signature C>T mutations in critical genes.
Volume: 35
Issue: 25
Pages: 3342-50
Publication  
First Author: Katz IS
Year: 2016
Journal: DNA Repair (Amst)
Title: 7,12-Dimethylbenz(a)anthracene-induced genotoxicity on bone marrow cells from mice phenotypically selected for low acute inflammatory response.
Volume: 37
Pages: 43-52
Publication
First Author: Wei Z
Year: 2018
Journal: Lipids Health Dis
Title: Omega 3 polyunsaturated fatty acids inhibit cell proliferation by regulating cell cycle in fad3b transgenic mouse embryonic stem cells.
Volume: 17
Issue: 1
Pages: 210
Publication  
First Author: Xia RM
Year: 2021
Journal: Front Cell Dev Biol
Title: LHPP-Mediated Histidine Dephosphorylation Suppresses the Self-Renewal of Mouse Embryonic Stem Cells.
Volume: 9
Pages: 638815
Publication
First Author: Hong JT
Year: 2001
Journal: Mol Carcinog
Title: Inhibitory effect of glycolic acid on ultraviolet-induced skin tumorigenesis in SKH-1 hairless mice and its mechanism of action.
Volume: 31
Issue: 3
Pages: 152-60
Publication
First Author: Moore GD
Year: 1996
Journal: Mol Reprod Dev
Title: Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
Volume: 45
Issue: 3
Pages: 264-75
Publication  
First Author: Jojima T
Year: 2019
Journal: Int J Mol Sci
Title: The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
Volume: 20
Issue: 20
Protein
Organism: Mus musculus/domesticus
Length: 119  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 99  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 75  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 125  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 96  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 189  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 156  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 295  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 289  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 292  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 295  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 214  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 243  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 250  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 292  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 310  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 295  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 292  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 289  
Fragment?: false